메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
한국병원약사회 병원약사회지 병원약사회지 제35권 제3호
발행연도
2018.1
수록면
319 - 330 (12page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background : Patients admitted to an intensive care unit (ICU) present with diseases and conditions of high severity and are at high risk of adverse drug events (ADEs). In previous studies, pharmacist’s intervention has been shown to reduce the length of ICU day and enhance clinical effects. Since May 2015, a pharmacist has attended rounds in the medical ICU (MICU) at a severance hospital. Methods : From January 2014 to December 2014 and from January 2016 to December 2016, the intervention data were analyzed and clinical effects were estimated by reviewing the electronic medical records of patients admitted to the MICU. Results : During 2016, the number of interventions for MICU was 1202, which is significantly more than that for 2014, when 850 (70.7%) interventions were performed through individual review; also, the rate of acceptance in 1202 was higher than that in 2014. The most common intervention type was dose adjustment (589, 49%), followed by drug recommendation (250, 20.8%) and unnecessary prescription (124, 10.3%). The result of evaluating the clinical effects showed that the length of stay in the MICU tended to be shorter (9 days vs. 5 days, p 0.001) and the ICU mortality rate decreased (29.0% vs 22.1%, p=0.002). Conclusions : The applications of interventions through individual review have been more readily accepted by physicians than those through data processing. Participation of the pharmacist in the ICU team was associated with appropriate drug use and clinical efficacy of patients.

목차

등록된 정보가 없습니다.

참고문헌 (14)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0